Background
Erectile dysfunction, one of the most complained problems during sexual intercourse, is defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual performance [
1], which has been paid more and more attention for its` association with poor quality of male’s sexual life [
2] and high prevalence. Epidemiological studies indicated that in 1995 erectile dysfunction (ED) affected over 150 million men worldwide and the prevalence will reach 322 million by 2025 [
3], which could be a great healthy burden to the society for its high prevalence in the general population and tight association with life quality impairment [
4].
Obesity, especially morbid obesity, is associated with a broad range of medical and psychosocial comorbidities which impose a negative effect on patients’ lives and health-care systems, including non-insulin dependent diabetes mellitus, coronary heart disease, stroke and hypertension [
5‐
8]. Evidence from a large number of studies have shown relationships between obesity and derangements in sexual function [
9‐
11]. It was reported that the occurrence of ED was higher in obese males than in those of normal weight [
12]. Sarwer et al. [
11] demonstrated in their study that 36% of men seeking bariatric surgery reported erectile dysfunction. Moore et al. [
13] reported in their study 45% of obese men who seek weight reduction met diagnostic criteria of erectile dysfunction. Laumann et al. [
4] reported in the United States that the prevalence of sexual dysfunction in general male population was 31%.
Several managements have been introduced to deal with obesity. Dietary intervention, medications, physical exercise are widely used in case of mild and moderate obesity [
14]. Meanwhile, bariatric surgery has become the most effective treatment strategy for morbid obese patients which can bring great weight reduction and is expected to ameliorate the comorbidities [
15,
16]. The bariatric surgical procedures, including gastric bypass, vertical sleeve gastrectomy, and biliopancreatic diversion, are recommended for class 2 obesity associated with comorbidities and for class 3 obesity (body index [BMI] 35–39.9 kg/m
2 and > 40 kg/m
2;respectively) [
17].
As an effective procedure in promoting weight loss and improving obesity-related physical comorbidities, bariatric surgery is now widely performed on obese patients [
18‐
21]. A number of studies have studied the effect of bariatric surgery on male’s sexual function while the results are inconsistent. Significant improvement was observed in some studies but not in the other studies. Hence, we performed the systemic review and meta-analysis to investigate the efficacy of bariatric surgery in promoting male’s sexual function.
Methods
Before conducting a systematic literature search, we formulated a protocol to standardize the process of literature review and data extraction which is agreed by all the authors.
Inclusion and exclusion criteria
Two independent reviewers separately assessed each study based on the inclusion and exclusion criteria to determine whether the study is eligible. Studies meeting the following criteria were included: (1) self-control study, (2) randomized controlled trials which use bariatric surgery as intervention, (3) at least one of the erectile function assessment score system (IIEF score and BSFI score) was assessed and reported. For exclusion, we eliminated studies which met the following criteria: (1) only females were recruited as the study subjects, (2) either perioperative data or postoperative data was missing or not recorded, (3) reviews, letters, technical reports, case reports, comments and case series studies. Publications based on the same study (e.g. same authors, institutions, period of study) were discussed, and only the best-quality study was included.
Search strategy
We searched PubMed, EMbase, The Cochrane Library, CNKI and Clinical
Trails.gov for English-language studies published before May 2019. Search terms included bariatric, laparoscopic Roux-and-Y gastric bypass, gastric bypass surgery, obesity, erectile dysfunction and sexual function. Reference lists of related articles, reviews, meta-analysis and other types of articles were also searched manually to identify additional eligible studies.
Study selection
Two reviewers independently reviewed the titles and abstracts of all retrieved studies. The full texts of studies which are deemed to be relevant studies were reviewed in details after the initial screening.
For each included study, we extracted data by two independent reviewers. Parameters including leading author, country, patient composition, methods for recruitment, baseline IIEF (or BSFI) score, postoperative IIEF (or BSFI) score and postoperative time point for SF assessment were recorded. We used the five-question International Index of Erectile Function (IIEF) score and BFSI score before and after bariatric surgery as the main reference index to evaluate the erectile function.
Quality assessment
We used a modified version of the methodological index for non-randomized studies’ (MINORS[ [
22,
23]: Table
1) checklist to assess methodological quality of the included systematic reviews. The checklist contains the following 8 aspects: (1) a clearly stated aim, (2) inclusion of consecutive patients, (3) prospective collection of data, (4) endpoints appropriate to the aim of the study, (5) unbiased assessment of the study endpoint, (6) follow-up period appropriate to the aim of the study, (7) loss to follow up less than 5%, (8) prospective calculation of the study size.
Table 1
Quality assessment for all of the included studies
| 2 | 2 | 1 | 2 | 1 | 2 | 2 | 1 | 13 |
| 2 | 2 | 2 | 2 | 1 | 2 | 2 | 1 | 14 |
| 2 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 14 |
| 2 | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 14 |
| 2 | 2 | 1 | 2 | 1 | 2 | 2 | 1 | 13 |
| 2 | 1 | 2 | 2 | 2 | 1 | 2 | 1 | 13 |
| 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 15 |
| 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 15 |
| 2 | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 13 |
| 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 15 |
| 2 | 1 | 2 | 2 | 1 | 2 | 2 | 1 | 13 |
Data analysis
We performed the meta-analysis by using the Cochrane Review software (Review manager v.5.3 for windows). To analyze the categorical variables, the Cochran-Mantel-Haenszel test was conducted and the forest plots was performed to show the results. Heterogeneity analysis uses the I2 test to define the statistic heterogeneity between each study. The heterogeneity was deemed to be acceptable and fixed model was used if the I2 was less than 50%, while the heterogeneity was considered high and the random model was used if the I2 was greater than 50%.
Disscussion
Obesity has been a worldwide health problem and can adversely affect sexual functioning. In the Massachuster Male Aging Study [
31], the average prevalence of erectile dysfunction in men who were not overweight was 13% while the altered prevalence in those who were overweight at baseline was 22%. Nowadays, the bariatric surgery has become the predominant treatment for morbid obesity and is reported to be the most effective option for weight loss in the severely obese people who have excessive fat accumulation [
36]. The previous studies have documented favorable clinical outcomes after bariatric surgery which can lose weight effectively and bring significant reduction in the disease-specific risk of death [
18]. However, relevant researches, investigating the correlation between the bariatric surgery and male’s sexual function, are insufficient. Meanwhile, the definitive causal link between bariatric surgery and male’s sexual function has not been widely studied. Moreover, some relevant studies which investigated the effect of bariatric surgery on male’s sexual function of morbidly obese patients were somewhat limited by lacking of sample sizes, indefinite results, and are of low credibility. Thus, we performed the meta-analysis to make a comprehensive analysis of those studies in order to investigate whether bariatric surgery contributes to improvements on male’s erectile function.
To our knowledge, this is the first meta-analysis to evaluate the effect of bariatric surgery on male’s sexual function with both IIEF scores and BSFI scores enrolled for comparison. Though a previous meta-analysis, by Glina et al. [
34], was also performed to assess the effect of bariatric surgery on male’s erectile function change, they only discussed the IIEF change and only 7 studies were enrolled for analysis.
The meta-analysis results indicate that bariatric surgery presents conspicuously effective improvements on male’s sexual function by comparing IIEF scores, including erectile function, intercourse satisfaction, overall satisfaction, orgasmic function, sexual desire, total erectile function and BSFI scores, including erection, ejaculation, problem assessment, sexual satisfaction. According to Aleid et al. [
29], the male’s sexual function improvements after bariatric surgery could be reflected by increasement of all the IIEF domains. This could be in accordance with the study performed by Efthymious et al. [
14] and other researchers [
24,
26,
27]. In contrast, in studies undertaken by Ranasinghe et al. [
25] and Sarwer et al. [
11], which also used IIEF to assess male’s sexual function, they found no significant improvement of erectile function among obese men undergoing bariatric surgery. Dallal et al. [
31], retrospectively studied 97 obese men who had undergone gastric bypass surgery with a mean postoperative follow-up length of 19 months. In this study, they found that scores of all domains of the BSFI including sexual drive, erectile function, ejaculatory function and sexual satisfaction improved postoperatively. Meanwhile, the postoperative BSFI scores approached the reference controls. This is in accordance with our findings which indicated significant improvements on all domains of BFSI score.
However, the underlying mechanism of obesity-related sexual dysfunction has not been clearly elucidated. Previous studies suggested that psychological and social appearance, such as body image, depression and so on, have a negative impact on self-esteem and the tendency of avoidance and initiation to sexual behavior [
35]. Negative effect of the comorbidities in obese people (diabetes, hypertension, metabolic syndrome, etc.) have already been clearly associated with sexual dysfunction [
10,
31,
37]. A correlation of sex hormones to sexual function has also been confirmed, which was believed to be associated with obesity induced sexual dysfunction [
38,
39]. Meanwhile, a number of biological mechanisms might account for the connection between obesity and sexual dysfunction. Obesity is a condition of inflammation and chronic oxidative stress [
40]. It was suggested that obesity is linked to endothelial dysfunction and increased serum concentrations of vascular inflammatory makers [
41,
42]. The visceral adipose tissue can secrete biochemical modulators and proinflammatory factors, such as IL-6, TNF-α, angiotensinogen, angiotensin-converting enzyme and so on, which can be obviously associated with systemic and peripheral vascular inflammation and can subsequently lead to a decrease in NO synthase and NO activity, an increase in adhesion molecules, MCP-1 and M-CSF, finally causing endothelial dysfunction [
43‐
45]. Moreover, the reduced adiponectin level has been confirmed to be connected with endothelial dysfunction [
46,
47]. The endothelial dysfunction causes erectile dysfunction by influencing the structural integrity of the vascular bed in the penis and the progress of penile engorgement by reducing the blood flow of penile [
48]. It can ameliorate endothelial function by increasing vasodilation in which the endothelium plays an important role, increasing the level of activation marks of endothelium and decreasing the level of proinflammatory factor when obese patients proceed to loss weights [
49]. Furthermore, the sex hormones have considerable correlation with sexual dysfunction. It is reported that the abnormalities in sex hormone regulation and production are related to sexual dysfunction in men [
50,
51]. It has been confirmed that androgens are essential in maintaining the libido and regulating erectile capacity in men [
52]. But BMI is negatively associated with serum testosterone in some studies. It was reported that a reduction in free testosterone of 1.35 pg/mL and a reduction in total testosterone of 11.79 ng/dL could be expected while the weight increases 4.5 kg [
53]. Previous studies found a positive relationship between estradiol levels and BMI index in men [
54]. And the reduction of estradiol levels is thought to be associated with weight loss. Thus, the feedback inhibition on LH secretion is removed and the testosterone secretion is enhanced. This mechanism was supported by European Male Aging Study, in which a negative correlation between body weight and total testosterone, free testosterone and sex hormone-binding globulin (SHBG) was reported [
55].
There are some limitations of our study. (1) Language bias might limit the generalizability of the findings. (2) Patient self-report is the current standard of male sexual function assessment in this study. (3) Included sample sizes are small. (4) The indexes for evaluating male’s sexual function, including IIEF score and BSFI score are simple, and are not both reported in all studies. (5) The length of follow-up is relatively short and long-term results are not available. Those limitations might lead to the analysis bias and influence the reliability of our study.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.